Objective: To evaluate the effect of seasonal variations in UV B-exposure on calcium absorption and bone turnover in young women with the overall goal to assess the potential bene®t of a vitamin D supplementation during wintertime. Design: Cross-sectional study. Setting: Area of Bonn, Germany (51 N). Subjects: Thirty-eight women (24.5 AE 0.5 y) studied in winter and 38 females of the same age (24.7 AE 0.4 y) studied in summer. Results: As estimated by a 4 d food record, both groups had similar dietary calcium and phosphorus intakes (b1200 mgad, respectively) covering actual recommendations. Signi®cant reductions in serum concentrations of 25-hydroxyvitamin D (25OHD) and calcitriol, fractional calcium absorption (Fc 220 , measured by means of a stable strontium test), 24 h urinary calcium and 24 h urinary phosphorus excretion were observed during wintertime. 25OHD but not calcitriol was correlated with Fc 220 values and with 24 h urinary phosphorus excretion. Moreover, Fc 220 was related to 24 h urinary calcium excretion. Fasting 2 h-urinary deoxypyridinoline concentrations (biomarker of bone resorption) and serum levels of carboxyterminal propeptide of type I procollagen (biomarker of bone formation) showed no differences between summer and winter. Conclusions: Our data indicate a decrease in intestinal calcium and phosphorus absorption during wintertime, most likely because of a reduction in serum 25OHD levels. Since bone turnover was not affected by the seasonal differences in mineral metabolism, there is no objective for young women with high calcium intake to supplement vitamin D during wintertime.
Introduction
In humans, cutaneous synthesis is a major source of vitamin D (cholecalciferol). UV B-light (290 ± 315 nm) initiates the transformation of the precursor 7-dehydrocholesterol to yield precholecalciferol. In a thermally induced process 80% of that latter metabolite is converted into cholecaliferol within 8 h (Holick, 1994) .
In western and northern Europe the intensity of UV-B exposure shows marked seasonal variations. Consequently, no or only marginal production of precholecalciferol occurs even in sunlight exposed human skin for several months, for example during November and February at 42 N and during mid-October to mid-April at 52 N (Holick, 1994) . Current studies brought evidence forward that this failure to endogenously synthesize precholecalciferol seriously impairs the vitamin D status. In free living elderly subjects, signi®cant variations in serum 25-hydroxyvitamin D (25OHD) concentrations, low at the end of winter, high at the end of summer, have been reported (McKenna, 1992) . A decreased bone mineral density has been found in postmenopausal women at low UV B-exposure (Dawson-Hughes et al, 1991) . In line with these biochemical data, the incidence of hip fractures is enhanced during wintertime (Jacobsen et al, 1990) . To reduce wintertime bone loss, a daily vitamin D supplementation (10 mg) is, thus, recommended for postmenopausal women (DawsonHughes et al, 1991) .
Very little information about seasonal¯uctuations in vitamin D status and bone health in young subjects is available. Variations in serum 25OHD and urinary calcium secretion but no change in alkaline phosphatase, serumosteocalcin (biomarkers of bone formation) and urinary hydroxyproline (biomarker of bone resorption) have been observed in young males and females (Vanderschueren et al, 1991) . A reduction in serum 25OHD of young subjects during wintertime has been found in several studies in western and northern Europe (McKenna, 1992) .
This present study was aimed at evaluating seasonal effects on calcium absorption and bone turnover in young women. The results are used to assess the potential bene®t of a vitamin D supplementation during wintertime.
Materials and methods

Subjects
A total of 76 young women, living in the region of Bonn, Germany (latitude: 51 N) were enrolled in the study, 38 subjects in February (winter group) and 38 subjects during July to October (summer group). Exclusion criteria (questionnaire) were diseases in¯uencing calcium and bone metabolism like hyper-and hypothyreodism, hyperparathyreodism, diabetes mellitus and celiac disease, intake of glucocorticoids andaor antibiotics, acute infections and eating disorders like anorexia and bulimia nervosa. Pregnancy was excluded by use of standard tests one day before actual examinations. There were no differences in age, weight, height, body mass (BMI), endogeneous 17-b-estradiol levels (measured on the day of actual examinations) and the use of oral contraceptiva (OC) between the winter and the summer groups (Table 1) . Written, informed consent was given by each subject. The study protocol was approved by the ethical committee of the University of Bonn.
Study protocol
Nutrient intake (day 1 ±4). A prospective standardized 4 d food record was completed by each subject. Intake of mineral water and fruit juices had to be speci®ed, furthermore, intake of calcium supplements had to be listed. Nutrient content of the diets was quanti®ed using a computer program based on the Bundeslebensmittelschluessel (BLS II.1). The compliance of the protocol was proved by 24 h urinary nitrogen excretion.
Blood and urine sampling (day 4 5). On day 4, a 24 h urine sample was collected from 7.00 am until 7.00 am the following morning. On the morning of day 5 (after overnight fast) blood was harvested from the vena cubitalis (serum monovettes). A urine sample (second spontaneous urine) was collected at 9.00 am (before breakfast). Aliquots of samples were frozen consecutively at 720 C until analysis.
Anthropometry (day 5). Weight and height of the subjects were measured (without shoes and indoor clothing). Body mass index (BMI) was calculated as weight divided by height squared (kgam 2 ).
Strontium test (day 5). Fractional calcium absorption (Fc 220 ) was assessed in each subject by a stable strontium test as previously described (Zittermann et al, 1995) . Brie¯y, after overnight fast, blood (see above) was harvested for determination of baseline serum strontium level, then, subjects received a standardized breakfast (one roll, 5 g butter) with 200 ml apple juice, including 2.27 mmol of strontium chloride hexahydrate (Merck, Wiesbaden, Germany), this meal contained 0.625 mmol calcium. A second blood sample was collected 220 min after ingestion of the breakfast; after breakfast, the subjects were not allowed to eat, drink or smoke.
Calculation of Fc 220 has to consider netto serum strontium levels (t 220 7 t 0 ) as well as the respective distribution volume (extracellular¯uid). Estimation of distribution volume was based on bioimpedance analysis (BIA) using a single frequency 50 kHz, 800 mA device (BIAMED, Cologne, Germany) on the morning of the strontium test. Total body water (TBW) was then used to calculate Fc 220 according to the formula (Zittermann et al, 1995) :
with totSrS: total strontium concentration in serum; V s : serum volume (TBW60.10); UFSrS: ultra®ltrable strontium in serum (67% of total serum strontium); V ex : volume of extravasal compartment (TBW60.30).
Analytical procedure Serum 25OHD was analysed using a commercially available radioimmunoassay kit (Sorin, Du Èsseldorf, Germany).
The intra-and interassay coef®cients of variation (CV) were 6.1% and 15.0%, respectively. Serum calcitriol was extracted using a column technique and subsequently analysed by a radio receptor assay, using a calf thymus cytosol binding protein (Hollis, 1986) . Intra-and interassay CVs were 5.4% and 9.3% respectively. Serum carboxy-terminal propeptide of type I procollagen (PICP), a biomarker of bone formation, was measured by means of enzyme linked immunosorbent assay using a commercial kit supplied by Biermann GmbH (Bad Nauheim, Germany; intra-and interassay CV: 5.5% and 5.0%, respectively). 17-b-estradiol (E 2 ) concentrations were measured in serum samples by means of enzyme-linked immunosorbent assay using a commercial kit supplied by IBL (Hamburg, Germany; intra-and interassay CV 6.0% and 7.1%, respectively). Serum strontium was measured by means of graphite furnace atomic absorption spectrophometry (HGA-500, Perkin Elmer, U È berlingen, Germany). The CV within a day was 4.8% and day-to-day 3.9%, respectively.
Concentrations of calcium and phosphorus in serum and 24 h urine were analysed using¯ame atomic absorption photometry (Paschen, 1970 ) and a colorimetirc assay (Goldenberg & Fernandez, 1966) , respectively. The CVs for these methods were`2.5%. Urinary nitrogen was analysed by high sensitive chemiluminescence (Grimble et al, 1988) . Imprecision of this method was 2.8% with in one day. Concentrations of deoxypyridinoline (Dpd), a biomarker of bone resorption, was measured in the 2 h urine samples using a commercial enzyme linked im-munosorbent assay (Biermann GmbH, Bad Nauheim, Germany, intra-and interassay CV 6.1% and 8.2%, respectively). Urinary creatinine was measured by the Jaffe Â reaction. All results for urinary calcium, phosphorus and deoxypyridinoline were expressed in relation to urinary creatinine excretion.
Statistics
Statistical analyses were performed with the Statistical Package for the Social Sciences (SPSSaPC ). Data were tested for homogeneity of variance using the Kolmogorov ± Smirnov test. For comparative evaluation, two-tailed 
Results
Nutrient intakes did not vary between winter and summer groups (Table 2) . Mean dietary calcium intake was well above the recommended dietary intake of 900± 1000 mgad. Since urinary nitrogen excretion was 15% (winter group) and 17% (summer group) above the estimated dietary nitrogen intake, food intake was slightly underreported. Signi®cant seasonal variations occurred in serum 25OHD and calcitriol levels (Table 3) . Interestingly, there was no correlation between 25OHD and calcitriol levels (r 0.13; n.s.). Moreover, dietary vitamin D intake was not correlated with serum 25OHD levels (r 0.20; n.s.). Serum levels of calcium and phosphorus were similar in both groups (Table 3) . However, in addition to variations in vitamin D status Fc 220 , 24 h urinary calcium and 24 h urinary phosphorus excretion (Table 3) were signi®cantly decreased during wintertime. No seasonal differences were observed in Dpd and PICP concentrations (Table 3) .
Using Pearson's linear correlation, Fc 220 was signi®-cantly correlated with 24 h urinary calcium excretion (r 0.28; P`0.01). Moreover, Fc 220 was associated with serum 25OHD levels, but not with serum calcitriol concentrations (Figure 1a , b) or with dietary calcium intake ( Figure 2) . No correlation was found between Fc 220 , 25OHD and biomarkers of bone metabolism, respectively (data not shown). Daily urinary phosphorus excretion was signi®cantly related to daily urinary calcium excretion (r 0.56; P`0.0001), serum 25OHD levels (r 0.23; P`0.05) and dietary phosphorus intake (r 0.27; P`0.01), but not to serum calcitriol concentrations (r 70.071; n.s.).
Discussion
Using a cross-sectional study design, we have investigated the effects of seasonal variations in UV-B-exposure on calcium absorption and bone turnover in young females. As con®rmed in previous studies (Need et al, 1993; DawsonHughes et al, 1997; Tsai et al, 1997 ) such a design can be used to reliably evaluate seasonal variations. Prerequisite is a similar pattern of decisive factors like age, body mass index, use of oral contraceptiva and endogeneous estrogen status in the populations. Obviously, this requirement was ful®lled in our study (Table 1) . Moreover, nutrient intake did not differed between the study groups (Table 2 ) and the mean dietary calcium intake was well above the recommended dietary allowances for females at this age (900 ± 1000 mgad) (Deutsche Gesellschaft fu Èr Erna Èhrung, 1991). Dietary vitamin D intake was comparably low in both groups. It is, thus, to assume that the alterations in calcium and bone metabolism are prominently affected by differences in UV-B-exposure.
In our study we have used a modi®ed strontium test to evaluate fractional calcium absorption (Zittermann et al, 1995) . Although the absolute absorption rate for the positively charged strontium ion is only half as high as the true fractional calcium absorption (Milsom et al, 1987; Blumsohn et al, 1994a; Sips et al, 1997) , a linear correlation between strontium and calcium uptake could be demonstrated in numerous studies (Milsom et al, 1987; Blumsohn et al, 1994; Sips et al, 1994) . Therefore, the strontium test , 1995) . The validation of our modi®ed test con®rmed its reproducibility and sensitivity (Zittermann et al, 1995) . The seasonal variation in fractional strontium absorption in our population groups (Table 3 ) mirrors a reduction of at least 5% in calcium absorption during wintertime. The amount of available calcium was, thus, decreased by 60± 70 mgad. The mean fractional strontium absorption measured in winter (Table 3 ) was, however, well above values reported in postmenopausal women (11.9 AE 0.34%; Devine et al, 1993 ) using a similar test protocol. This can be interpreted that the effects of age andaor estrogen status on intestinal calciumastrontium absorption (Heaney et al, 1989; Gennari et al, 1990; Horst et al, 1990) are more pronounced than the in¯uence of UV-B-exposure.
It is still believed that calcitriol is the most important regulator of calciumastrontium absorption in animals and humans (Sips et al, 1997) . Interestingly, Fc 220 and calcitriol levels were not correlated in our study. Comparable observations have been reported in current cross-sectional studies (Eastell et al, 1991; Devine et al, 1993; Barger-Lux et al, 1995) . It is, thus, to mention that calcitriol alone cannot explain changes in absorption rates. In line with recently published data of Barger-Lux and colleagues (1995) in premenopausal women we observed a signi®cant correlation between serum 25OHD levels and Fc 220 values ( Figure  1 ). Consequently, 25OHD seems to be a better predictor for calcium absorption ef®ciency. Colodro et al (1978) reported that on a molar basis the physiologic activity of 25OHD relative to calcitriol ranges from 1:400 to as much as 1:125 in humans. Considering that serum 25OHD levels are approximately 10 3 times higher than serum calcitriol concentrations (Table 3) , seasonal changes in 25OHD levels may well explain differences in fractional calcium absorption rates.
At intakes above 1000 mgad, intestinal calcium absorption still accounts for half of total calcium uptake (Schaafsma, 1988) . Thus, the up-regulation of the receptor-mediated calcium transport by the seasonal rise of 25OHD levels in summer (Table 3) decisively improved calcium availability. The lack of correlation between calcium intake and Fc 220 (Figure 2) can be explained by the generally high intake.
Although more calcium and phosphorus was available during summertime, serum levels did not vary between the groups (Table 3) . Under physiologic conditions, calcium serum concentrations are homeostatically controlled. Maintenance of serum calcium can be made by bone mineralization andaor increased loss. As shown in Table 3 , 24 h urinary excretion was enhanced during summertime thereby con®rming previous studies on the in¯uence of season on urinary calcium excretion (Robertson et al, 1974; Vanderschueren et al, 1991) . Phosphorus excretion resembled that of calcium with higher values in summer and lower in winter (Table 3) . Since no differences existed in dietary phosphorus intake between the groups, these data indicate an increase in intestinal absorption ef®ciency in summer. In addition to the passive route (Anderson, 1991) , phosphorus can be taken up by a calcitriol-mediated active transport as has been described in both normal subjects and uremic patients (Brickman et al, 1973) . Again, serum 25OHD but not calcitriol levels were correlated with urinary phosphorus excretion, indicating a physiologic role of 25OHD in the process of gastrointestinal phosphorus uptake.
To evaluate bone turnover, we measured serum levels of PICP as well as urinary Dpd excretion. PICP is considered 
Vitamin D status and calcium absorption
A Zittermann et al a sensitive biomarker of bone formation. Since PICP is released into the circulation from the precursor procollagen molecule in stoichiometric amounts (Prockop et al, 1979) , the PICP level seems to be related to the number of collagen molecules formed (Melkko et al, 1990) . Serum PICP levels are associated with histomorphometric parameters of bone formation (Par®tt et al, 1987; Ericksen et al, 1993) . Dpd is mainly present in bone collagen; urinary secretion of this solute reports the degradation of mature collagen (Robins, 1995) . Dpd measured in fasting 2 h urine samples strongly correlates with the rate of bone loss (Uebelhart et al, 1991) . Urinary Dpd is in¯uenced by several factors affecting bone homeostasis including menopause and hormone replacement therapy (Uebelhart et al, 1991) . Since urinary Dpd excretion underlies rapid changes within one day (Blumsohn et al, 1994b) this parameter might be a sensitive marker to assess bone resorption.
Surprisingly, the seasonal decrease in calcitriol and 25OHD levels did not effect serum levels of PICP and fasting urinary Dpd in our population of young women (Table 3) . Moreover, serum 25OHD was not correlated with PICP or Dpd. These results strongly indicate that the seasonal variations in vitamin D, calcium and phosphorus metabolism were not associated with changes in bone turnover. These results con®rm a previous report on biochemical markers of bone turnover in danish women (age: 29 ±53 y) (Overgaard et al, 1988) . Interestingly, 40 ±72 y old chinese women living in a subtropical region showed high serum 25OHD levels (Tsai et al, 1997) . Similar to our study, there was no correlation between 25OHD levels and markers of bone formation (PICP, bone speci®c alkaline phosphatase, osteocalcin) or bone resorption markers (Nterminal crosslinked fragment of type I collagen). However, opposite results have been reported in a cross-sectional study in elderly women (b60 y; Peacock et al, 1993) as well as in a representative population of postmenopausal women in Southern Germany (Scharla et al, 1996) . In the latter study, serum 25OHD levels were negatively correlated with urinary Dpd excretion, and positively related to bone mineral density of the proximal femur. The absolute serum 25OHD levels measured in winter (44.8 AE 22.5 nmolaL) and in summer (67.8 AE 25.0 nmolaL) were comparable to those analysed in our young women (Table 3) . Indeed, serum 25OHD levels are generally not correlated with age (Burnand et al, 1992) . Only in very old subjects the serum 25OHD levels signi®cantly decrease presumably due to low cutaneous vitamin D synthesis (Chapuy et al, 1996) .
Obviously, young and elderly female subjects differ concerning the effect of vitamin D on bone metabolism, even when serum 25 OHD levels of both age groups are similar. High calcium intake, maintained estrogen levels and low chronological age may all contribute to the reduced bone sensitivity of young females facing changes in vitamin D status.
In line with this interpretation, bone metabolism of our young female population did not bene®t from the 25OHD-mediated increase in Fc 220 . Consequently, the additionally absorbed amount of dietary calcium must have been eliminated from the systemic circulation by another route. Most likely, a rise in total calcium excretion as shown for 24 h urinary calcium loss (Table 3) is involved in this process. Therefore, an increased ef®ciency of calcium absorption is not necessarily associated with positive effects on bone in young females.
Previous results support the concept that calcium is a threshold nutrient (Matkovic & Heaney, 1992) . When a plateau is reached, a greater amount of absorbed calcium does not cause further gain in calcium retention. As determined by calcium balance studies, maximal calcium retention may occur at an intake of 957 mg calciumad in young adults (Matkovic & Heaney, 1992) . However, no data have been provided on vitamin D status of the subjects. Our results indicate that at a mean serum 25OHD level of 30 nmolaL during wintertime, a calcium intake of 1250 mgad is adequate to cover calcium requirements for optimal bone health. It might be worth to further investigate the relation between 25OHD levels, calcium intake and calcium absorption.
Conclusions
We could demonstrate seasonal differences in fractional calcium absorption, in urinary calcium and in urinary phosphorus excretion. This effect of season most likely depends on variation in serum 25OHD levels. Decreased vitamin D status and reduced fractional calcium absorption in winter had no effect on bone turnover due to a diminished vitamin D susceptibility of young women. Thus, with a high calcium and phosphorus intake (b1200 mgad) a vitamin D supplementation of young females is not required.
